S. 2508 · 119th Congress · Transportation and Public Works
Gas Pipeline Leak Detection and Repair Act of 2025
- IntroducedJul 29, 2025 Done
- CommitteeReferred to Commerce, Science, and Transportation Current stage
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Full text
No CRS summary yet · 150 wordsS. 2508 · Introduced in Senate · Jul 29, 2025
This Act may be cited as the Gas Pipeline Leak Detection and Repair Act of 2025 .
(a) In general. Notwithstanding any other provision of law, the final rule of the Pipeline and Hazardous Materials Safety Administration issued under section 60102(q) of title 49, United States Code, on January 17, 2025, relating to Pipeline Safety: Gas Pipeline Leak Detection and Repair (Docket No. PHMSA–2021–0039; RIN 2137–AF51) shall take effect on the date of enactment of this Act.
(b) Subsequent updates. Nothing in this section prohibits the Secretary from updating any regulation promulgated or revised under this section or section 60102(q) of title 49, United States Code, to provide protections or standards that are more stringent than those provided by the rule made effective by subsection (a) or any other rule in effect as of the date of enactment of this Act.
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
2 organizations, more than 73% of Senate bills · 8 filings, incl. 8 naming only H.R. 4818 · Q3 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named S. 2508 or H.R. 4818 that quarter.
-
Healthcare Institute of New Jersey
5 of 5 quarters
“…Supporting the Treat And Reduce Obesity Act (H.R. 4818, S. 2407 in the previous Congress). Supporting the Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 5391 and S. 2764 in the previous Congress). Supporting the Rare Pediatric Disease Priority Review Voucher Act (H.R. 1262 and S. 932). Supporting…”
$148K lobbying spend in 2026 to date, all issuesQ3 2026 filing · names H.R. 4818 only
-
Eli Lilly & Company
3 of 5 quarters
“Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.”
$9.6M lobbying spend in 2026 to date, all issuesQ1 2026 filing · names H.R. 4818 only
Organizations that named S. 2508 or its companion H.R. 4818 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only H.R. 4818 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, H.R. 4818, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jul 29, 2025Read twice and referred to the Committee on Commerce, Science, and Transportation.
- Jul 29, 2025Introduced in Senate